Vision

To advance the development and utilization of safe and efficacious medicines through the application of Quantitative Systems Pharmacology (QSP)

Consistent with this Vision, we will:

• Advance the science of QSP by fostering a community for the exchange of ideas and knowledge

• Promote the application of QSP in drug development and regulatory decision-making

• Develop and maintain information resources for its members, including establishment of “best practices” for QSP approaches

• Facilitate communication and advance knowledge through sponsored sessions at professional meetings, white papers, discussion groups, and publications

What is Quantitative Systems Pharmacology?

The white paper below represents the NIH’s attempt to define the opportunities and challenges facing the field of quantitative systems pharmacology (QSP). The paper recommends the adoption of a holistic approach to understanding the interaction of drugs with human biology. The paper further notes that this will require the collaboration and training of scientists from multiple disciplines, from pharmacology to chemistry to computer science. We look forward to hearing from ideas from our SIG members about how these disciplines can be effectively synthesized so that QSP can continue to grow as a field.

www.nigms.nih.gov/News/reports/Documents/SystemsPharmaWPSorger2011.pdf

Are you interested in receiving updates and participating in SIG discussions? Join the ISoP QSP SIG today, click here. You can also participate in the QSP discussion forum at http://discuss.go-isop.org/c/systems-pharmacology

QSP Working Groups

Working groups are one of the best ways to get involved in the QSP-SIG and contribute your energy and passion to the advancement of the field. Over the last several years the QSP leadership had the privilege to endorse the formation of several working groups that have delivered outstanding achievements. All started with an idea and a few enthusiastic champions that have managed to get wider engagement from our community. We anticipate several working groups may end soon, having completed their objectives, and others may seek new membership to drive a transition to new objectives.

If you are interested, do not hesitate to contact us on our email: isop_qsp_sig@go-isop.org.

QSP SIG is pleased to announce the new working group:

• Drug Development Science